Fufang Huangbo Formula mitigates myeloproliferative neoplasms by activating p53/p21 signaling axis and inhibiting STAT3 and NF-κB signaling pathways
Authors: Mingjie Liu, Yanxia Li, Chengxue Qin et al.
Publication: Pharmaceutical Science Advances
Published: Dec 1, 2026
Source: Crossref